Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.050
Neutral
RSI(14)
46.057
Neutral
STOCH(KDJ)(9,3,3)
66.005
Buy
ATR(14)
0.499
Low Volatility
CCI(14)
38.616
Neutral
Williams %R
41.045
Buy
TRIX(12,20)
-0.466
Sell
StochRSI(14)
100.000
Overbought
Search
Amarin Corporation PLC
AMRNAdd to Watchlist
14.260USD
+0.030+0.21%
Close 07-31 16:00（ET）Quotes delayed by 15 min
301.21MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+0.21%
5 Days
+5.24%
1 Month
-12.89%
6 Months
-4.90%
Year to Date
+2.19%
1 Year
-5.94%
Key Figures
14.180Open
14.400High
59.62KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.28%Turnover Ratio
14.230Prev. Close
13.850Low
567.34KTurnover
LossP/E Static
0.68P/B
0.00%Div Yield TTM
-5.17%ROA
20.90052wk High
1.05Volume Ratio
-82.18MNet Profit
21.00MShares
-1.6122EPS TTM
0.82Beta
-7.28%ROE
11.27052wk Low
3.87%Amplitude
35.51%Gross Margin
301.21MMarket Cap
-3.52Reward/Risk
2.71%Risk Rate
TradingKey Stock Score of Amarin Corporation PLC
Currency: USD Updated: 2026-07-31Key Insights
Amarin Corporation PLC's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 161 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Sell, with the highest price target at 12.00.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Amarin Corporation PLC's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive
Amarin Corporation PLC Highlights
StrengthsRisks
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Fairly Valued
The company’s latest PE is -8.85, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 4.71M shares, decreasing 7.88% quarter-over-quarter.
Held by Steven Cohen
Star Investor Steven Cohen holds 239.67K shares of this stock.
Analyst Rating
Based on
1
analysts
Sell
Current Rating
12.000
Target Price
-26.70%
Upside Space
Amarin Corporation PLC News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
1
analysts
Sell
Current Rating
12.000
Target Price
-26.70%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Amarin Corporation PLC
AMRN
1
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
Indicators
Moving Average
Indicators
Value
Direction
MA5
14.082
Buy
MA10
13.880
Buy
MA20
14.341
Sell
MA50
14.807
Sell
MA100
14.763
Sell
MA200
15.187
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Amarin Corporation PLC Info
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Ticker SymbolAMRN
CompanyAmarin Corporation PLC
CEOBerg (Aaron D)
Websitehttps://amarincorp.com/
Shareholders
Related Instruments
-0.53%
+0.27%
-2.51%
+0.32%
-1.45%
-0.92%
-0.64%
-0.82%
-8.79%
+0.52%
+0.68%
-0.95%
-0.71%
+0.44%
-1.08%
+3.29%
0.00%
-0.90%
+1.30%
-2.15%Popular Instruments
52733.700
+355.700 (+0.68%)
28528.400
+367.500 (+1.30%)
7530.400
+55.300 (+0.74%)
14637.000
-112.000 (-0.76%)
63288.000
+436.000 (+0.69%)
6397.500
+32.100 (+0.50%)
79.092
-6.842 (-7.96%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4059.330
+17.900 (+0.44%)
FAQs
What is the current price of Amarin Corporation PLC (AMRN)?
The current price of Amarin Corporation PLC (AMRN) is 14.26.
What is the symbol of Amarin Corporation PLC?
The ticker symbol of Amarin Corporation PLC is AMRN.
What is the 52-week high of Amarin Corporation PLC?
The 52-week high of Amarin Corporation PLC is 20.90.
What is the 52-week low of Amarin Corporation PLC?
The 52-week low of Amarin Corporation PLC is 11.27.
What is the market capitalization of Amarin Corporation PLC?
The market capitalization of Amarin Corporation PLC is 301.21M.
Is Amarin Corporation PLC (AMRN) currently rated as Buy, Hold, or Sell?
According to analysts, Amarin Corporation PLC (AMRN) has an overall rating of Sell, with a price target of 12.00.
What is the Earnings Per Share (EPS TTM) of Amarin Corporation PLC (AMRN)?
The Earnings Per Share (EPS TTM) of Amarin Corporation PLC (AMRN) is -37.40.